Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Marimed (MRMD) over the last 12 years, with Q3 2025 value amounting to $559000.0.

  • Marimed's Capital Expenditures fell 7821.51% to $559000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 8653.81%. This contributed to the annual value of $12.0 million for FY2024, which is 4058.62% down from last year.
  • According to the latest figures from Q3 2025, Marimed's Capital Expenditures is $559000.0, which was down 7821.51% from $309000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Capital Expenditures registered a high of $6.7 million during Q3 2021, and its lowest value of $266000.0 during Q1 2025.
  • Over the past 5 years, Marimed's median Capital Expenditures value was $3.1 million (recorded in 2023), while the average stood at $3.1 million.
  • In the last 5 years, Marimed's Capital Expenditures soared by 46406.56% in 2021 and then tumbled by 9378.02% in 2025.
  • Marimed's Capital Expenditures (Quarter) stood at $3.2 million in 2021, then plummeted by 33.18% to $2.2 million in 2022, then skyrocketed by 149.7% to $5.4 million in 2023, then plummeted by 80.34% to $1.1 million in 2024, then tumbled by 47.16% to $559000.0 in 2025.
  • Its last three reported values are $559000.0 in Q3 2025, $309000.0 for Q2 2025, and $266000.0 during Q1 2025.